261 related articles for article (PubMed ID: 34980568)
21. Efficacy and feasibility of 3D printed redesigned Venezia™ applicator for treating advanced cervix and recurrent endometrial cancer.
Lee VWY; Yip WWL; Tang SYK; Leung MPH; Kwan KKK; Liu ACH; Chan VNY; Wu JWS; Cheng JNS; Chiang CL; Ho-Fun Lee V
Phys Med; 2023 Oct; 114():103150. PubMed ID: 37757501
[TBL] [Abstract][Full Text] [Related]
22. The Kelowna template for combined intracavitary and interstitial brachytherapy for gynecologic malignancies: Design, application, treatment planning, dosimetric and treatment outcomes.
Shiao JC; Holt DE; Stuhr K; Schubert L; Robin T; Fisher CM
Brachytherapy; 2022; 21(6):823-832. PubMed ID: 36192312
[TBL] [Abstract][Full Text] [Related]
23. Clinical applications of custom-made vaginal cylinders constructed using three-dimensional printing technology.
Sethi R; Cunha A; Mellis K; Siauw T; Diederich C; Pouliot J; Hsu IC
J Contemp Brachytherapy; 2016 Jun; 8(3):208-14. PubMed ID: 27504130
[TBL] [Abstract][Full Text] [Related]
24. Comparison of the Dosimetric Influence of Applicator Displacement on 2D and 3D Brachytherapy for Cervical Cancer Treatment.
Wu A; Tang D; Wu A; Liu Y; Qian L; Zhu L
Technol Cancer Res Treat; 2021; 20():15330338211041201. PubMed ID: 34569371
[TBL] [Abstract][Full Text] [Related]
25. Computed tomography-based three-dimensional dosimetry of intracavitary brachytherapy for cervical cancer.
Wadasaki K; Monzen Y; Kurose T; Okazaki H; Mito M
Jpn J Radiol; 2010 Dec; 28(10):740-5. PubMed ID: 21191739
[TBL] [Abstract][Full Text] [Related]
26. The Vienna applicator for combined intracavitary and interstitial brachytherapy of cervical cancer: design, application, treatment planning, and dosimetric results.
Kirisits C; Lang S; Dimopoulos J; Berger D; Georg D; Pötter R
Int J Radiat Oncol Biol Phys; 2006 Jun; 65(2):624-30. PubMed ID: 16690444
[TBL] [Abstract][Full Text] [Related]
27. Predicting which patients may benefit from the hybrid intracavitary+interstitial needle (IC/IS) applicator for advanced cervical cancer: A dosimetric comparison and toxicity benefit analysis.
Gonzalez Y; Giap F; Klages P; Owrangi A; Jia X; Albuquerque K
Brachytherapy; 2021; 20(1):136-145. PubMed ID: 33132073
[TBL] [Abstract][Full Text] [Related]
28. Three-dimensional-guided perineal-based interstitial brachytherapy in cervical cancer: A systematic review of technique, local control and toxicities.
Mendez LC; Weiss Y; D'Souza D; Ravi A; Barbera L; Leung E
Radiother Oncol; 2017 May; 123(2):312-318. PubMed ID: 28351521
[TBL] [Abstract][Full Text] [Related]
29. To evaluate the use of tandem and cylinder as an intracavitary brachytherapy device for carcinoma of the cervix with regard to local control and toxicities.
Gadda IR; Khan NA; Wani SQ; Baba MH
J Cancer Res Ther; 2022; 18(3):740-746. PubMed ID: 35900548
[TBL] [Abstract][Full Text] [Related]
30. Combined intracavitary and interstitial brachytherapy of cervical cancer using the novel hybrid applicator Venezia: Clinical feasibility and initial results.
Walter F; Maihöfer C; Schüttrumpf L; Well J; Burges A; Ertl-Wagner B; Mahner S; Belka C; Gallwas J; Corradini S
Brachytherapy; 2018; 17(5):775-781. PubMed ID: 29941345
[TBL] [Abstract][Full Text] [Related]
31. Transperineal low-dose rate iridium-192 interstitial brachytherapy in cervical carcinoma stage IIB.
Budrukkar AN; Shrivastava SK; Jalali R; Agarwal JP; Deshpande DD; Nehru RM; Dinshaw KA
Strahlenther Onkol; 2001 Oct; 177(10):517-24. PubMed ID: 11680016
[TBL] [Abstract][Full Text] [Related]
32. Dosimetric comparison of multichannel with one single-channel vaginal cylinder for vaginal cancer treatments with high-dose-rate brachytherapy.
Kim H; Rajagopalan MS; Houser C; Beriwal S
Brachytherapy; 2014; 13(3):263-7. PubMed ID: 24080298
[TBL] [Abstract][Full Text] [Related]
33. Clinical use of the Utrecht applicator for combined intracavitary/interstitial brachytherapy treatment in locally advanced cervical cancer.
Nomden CN; de Leeuw AA; Moerland MA; Roesink JM; Tersteeg RJ; Jürgenliemk-Schulz IM
Int J Radiat Oncol Biol Phys; 2012 Mar; 82(4):1424-30. PubMed ID: 21669505
[TBL] [Abstract][Full Text] [Related]
34. Applying 3D-Printed Templates in High-Dose-Rate Brachytherapy for Cervix Cancer: Simplified Needle Insertion for Optimized Dosimetry.
Marar M; Simiele E; Niedermayr T; Kidd EA
Int J Radiat Oncol Biol Phys; 2022 Sep; 114(1):111-119. PubMed ID: 35654306
[TBL] [Abstract][Full Text] [Related]
35. Image and laparoscopic guided interstitial brachytherapy for locally advanced primary or recurrent gynaecological cancer using the adaptive GEC ESTRO target concept.
Fokdal L; Tanderup K; Nielsen SK; Christensen HK; Røhl L; Pedersen EM; Schønemann NK; Lindegaard JC
Radiother Oncol; 2011 Sep; 100(3):473-9. PubMed ID: 21924784
[TBL] [Abstract][Full Text] [Related]
36. A Dosimetric evaluation of a high dose rate cobalt-60 brachytherapy source using shielded, single and multi-channel cylinder applicators for gynecological cancers.
Abtahi M; Safaei AM; Sheikhzade P; Gholami S
Med Dosim; 2022 Winter; 47(4):318-324. PubMed ID: 35907692
[TBL] [Abstract][Full Text] [Related]
37. Development of an indigenous low-cost multichannel cylinder applicator for vaginal tumors.
Bajwa HK; Singareddy R; Talluri AK; Guntupalli R; Raju AK; Sresty M; Ahmed A
Brachytherapy; 2020; 19(5):674-678. PubMed ID: 32540330
[TBL] [Abstract][Full Text] [Related]
38. Clinical feasibility of interstitial brachytherapy using a "hybrid" applicator combining uterine tandem and interstitial metal needles based on CT for locally advanced cervical cancer.
Liu ZS; Guo J; Lin X; Wang HY; Qiu L; Ren XJ; Li YF; Zhang BY; Wang TJ
Brachytherapy; 2016; 15(5):562-9. PubMed ID: 27474180
[TBL] [Abstract][Full Text] [Related]
39. Multicentre treatment planning study of MRI-guided brachytherapy for cervical cancer: comparison between tandem-ovoid applicator users.
Nomden CN; de Leeuw AA; Van Limbergen E; de Brabandere M; Nulens A; Nout RA; Laman M; Ketelaars M; Lutgens L; Reniers B; Jürgenliemk-Schulz IM
Radiother Oncol; 2013 Apr; 107(1):82-7. PubMed ID: 23127774
[TBL] [Abstract][Full Text] [Related]
40. 45 or 50 Gy, Which is the Optimal Radiotherapy Pelvic Dose in Locally Advanced Cervical Cancer in the Perspective of Reaching Magnetic Resonance Image-guided Adaptive Brachytherapy Planning Aims?
Mazeron R; Petit C; Rivin E; Limkin E; Dumas I; Maroun P; Annede P; Martinetti F; Seisen T; Lefkopoulos D; Chargari C; Haie-Meder C
Clin Oncol (R Coll Radiol); 2016 Mar; 28(3):171-7. PubMed ID: 26547694
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]